Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04857 |
| Species: | Mus musculus |
| Position : | chr15:98750000-98750480 |
| Year: | 2009 |
| Title: | Smad3 activates the Sox9-dependent transcription on chromatin. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chondrosarcoma |
| PMID: | 19041414 |
| MONDO: | MONDO:0008977 |
| Tissue: | cartilage tissue |
| Tissue Ontology ID: | UBERON:0002418 |
| Cell Source: | SW1353 |
| CVCL ID: | CVCL_0543 |
| Cell Type: | chondrosarcoma cell |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| Low Throughput Method: | Luciferase Reporter Assay; EMSA; In vitro transcription assay; Reporter assay |
| Target gene : | Col2a1 |
| TF name : | Sox9 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Sox9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| Sox9 | TGF_beta_Receptor | netpath | 220 |
| Sox9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| Sox9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |